Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Hiremath

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of the Association of Physicians of India|May 26, 2012
Future of thrombolytic therapy--an Indian contextJ S Hiremath
The Journal of the Association of Physicians of India|October 24, 2018
Dabigatran - the First Approved DTI for SPAFAbhijit Trailokya, J S Hiremath
The Journal of the Association of Physicians of India|March 12, 2026
Role of β-Blockers Across the Cardiovascular Continuum: A Real-World Perception Survey (ROBUST)J S Hiremath, Arup Dasbiswas, Jps Sawhney, et al.
The Journal of the Association of Physicians of India|October 13, 2016
Acenocoumarol: A Review of Anticoagulant Efficacy and SafetyAbhijit Trailokya, J S Hiremath, Jps Sawhney, et al.
The Journal of the Association of Physicians of India|July 18, 2019
A Randomized, Double-blinded, Controlled, Multicentre Phase III Study to Evaluate the Efficacy and Safety of Telmisartan /Amlodipine/Hydrochlorothiazide Compared to Telmisartan/Hydrochlorothiazide in Patients with Essential HypertensionJ S Hiremath, K Chokalingam, G Mathan, et al.
Cardiovascular Therapeutics|July 14, 2021
Correlation between Stroke Risk and Systolic Blood Pressure in Patients over 50 Years with Uncontrolled Hypertension: Results from the SYSTUP-India StudyRishi Sethi, J S Hiremath, V Ganesh, et al.
Indian Heart Journal|September 3, 2013
Pharmacologic reperfusion therapy with indigenous tenecteplase in 15,222 patients with ST elevation myocardial infarction - the Indian RegistryS S Iyengar, T Nair, J S Hiremath, et al.
Indian Heart Journal|November 30, 2012
Efficacy & safety of tenecteplase in 6000 patients with ST-elevation myocardial infarction from the Elaxim Indian RegistryS S Iyengar, Tiny Nair, J S Hiremath, et al.
Indian Heart Journal|July 20, 2010
Efficacy and safety of tenecteplase in ST elevation myocardial infarction patients from the Elaxim Indian RegistryS S Iyengar, Tiny Nair, I Sathyamurthy, et al.
American Heart Journal|July 24, 2007
Optimal platelet inhibition in patients undergoing PCI: data from the Multicenter Registry of High-Risk Percutaneous Coronary Intervention and Adequate Platelet Inhibition (MR PCI) studyH M Mardikar, M S Hiremath, David J Moliterno, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of the Association of Physicians of India|May 26, 2012
Future of thrombolytic therapy--an Indian contextJ S Hiremath
The Journal of the Association of Physicians of India|October 24, 2018
Dabigatran - the First Approved DTI for SPAFAbhijit Trailokya, J S Hiremath
The Journal of the Association of Physicians of India|March 12, 2026
Role of β-Blockers Across the Cardiovascular Continuum: A Real-World Perception Survey (ROBUST)J S Hiremath, Arup Dasbiswas, Jps Sawhney, et al.
The Journal of the Association of Physicians of India|October 13, 2016
Acenocoumarol: A Review of Anticoagulant Efficacy and SafetyAbhijit Trailokya, J S Hiremath, Jps Sawhney, et al.
The Journal of the Association of Physicians of India|July 18, 2019
A Randomized, Double-blinded, Controlled, Multicentre Phase III Study to Evaluate the Efficacy and Safety of Telmisartan /Amlodipine/Hydrochlorothiazide Compared to Telmisartan/Hydrochlorothiazide in Patients with Essential HypertensionJ S Hiremath, K Chokalingam, G Mathan, et al.
Cardiovascular Therapeutics|July 14, 2021
Correlation between Stroke Risk and Systolic Blood Pressure in Patients over 50 Years with Uncontrolled Hypertension: Results from the SYSTUP-India StudyRishi Sethi, J S Hiremath, V Ganesh, et al.
Indian Heart Journal|September 3, 2013
Pharmacologic reperfusion therapy with indigenous tenecteplase in 15,222 patients with ST elevation myocardial infarction - the Indian RegistryS S Iyengar, T Nair, J S Hiremath, et al.
Indian Heart Journal|November 30, 2012
Efficacy & safety of tenecteplase in 6000 patients with ST-elevation myocardial infarction from the Elaxim Indian RegistryS S Iyengar, Tiny Nair, J S Hiremath, et al.
Indian Heart Journal|July 20, 2010
Efficacy and safety of tenecteplase in ST elevation myocardial infarction patients from the Elaxim Indian RegistryS S Iyengar, Tiny Nair, I Sathyamurthy, et al.
American Heart Journal|July 24, 2007
Optimal platelet inhibition in patients undergoing PCI: data from the Multicenter Registry of High-Risk Percutaneous Coronary Intervention and Adequate Platelet Inhibition (MR PCI) studyH M Mardikar, M S Hiremath, David J Moliterno, et al.
Pageof 2